Qyuns Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Qyuns Therapeutics has a total shareholder equity of CN¥362.8M and total debt of CN¥498.6M, which brings its debt-to-equity ratio to 137.5%. Its total assets and total liabilities are CN¥1.1B and CN¥711.9M respectively.
Key information
137.5%
Debt to equity ratio
CN¥498.64m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥629.63m |
| Equity | CN¥362.78m |
| Total liabilities | CN¥711.94m |
| Total assets | CN¥1.07b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 2509's short term assets (CN¥712.6M) exceed its short term liabilities (CN¥382.9M).
Long Term Liabilities: 2509's short term assets (CN¥712.6M) exceed its long term liabilities (CN¥329.1M).
Debt to Equity History and Analysis
Debt Level: 2509 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2509's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2509 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 2509 has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 9.9% each year.